Prostate cancer screening can save four times as many lives than what was previously believed, new research has shown. The ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Please provide your email address to receive an email when new articles are posted on . Many men with lower life expectancy and localized prostate cancer get overtreated. Rates of definitive treatment ...

Treatment choice for localized prostate cancer depends on cancer aggressiveness and quality-of-life factors, such as sexual functioning. Active surveillance is a safe option for appropriate patients, ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

Add Yahoo as a preferred source to see more of our stories on Google. Thousands more men with prostate cancer will be eligible for a life-extending drug on the NHS. Currently, only men whose prostate ...

“Prostate cancer is not just an older man's problem,” says Eric Morrow, now 54 Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE for over 20 years. She reports on ...

Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...